PMID- 21272161 OWN - NLM STAT- MEDLINE DCOM- 20110615 LR - 20220321 IS - 1349-7006 (Electronic) IS - 1347-9032 (Linking) VI - 102 IP - 5 DP - 2011 May TI - c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor alpha protein in hepatic cells. PG - 934-41 LID - 10.1111/j.1349-7006.2011.01889.x [doi] AB - We previously reported that impaired retinoid signaling causes hepatocellular carcinoma (HCC) through oxidative stress. However, the interaction between oxidative stress and retinoid signaling has not been fully understood. To address this issue, the effects of hydrogen peroxide on the transcriptional activity of RAR/RXR heterodimers, RARalpha and RXRalpha proteins and intracellular signaling pathways were examined. The transcriptional activity of RAR/RXR examined by the DR5-tk-Luc reporter assay was significantly suppressed. The RARalpha protein level began to decrease at 6 h after treatment and declined thereafter. However, RARalpha mRNA were not changed. Activation of extracellular regulated kinases (ERK), p38, c-Jun N-terminal kinase (JNK) and Akt was observed after treatment of hydrogen peroxide. SP600125, an inhibitor of JNK, reversed the RARalpha protein level reduced by hydrogen peroxide. Anisomycin, an activator of JNK, reduced RARalpha protein. Transfection of wild-type JNK-constitutive actively expressing plasmid, but not kinase-negative JNK-expressing plasmid caused reduction of RARalpha protein. Proteasomal degradation of RARalpha was observed after anisomycin treatment; however, the mutant RARalpha, of which phosphorylation sites are replaced with alanines, was not degradated. In hepatitis C virus (HCV)-related human liver tissues, phospho-JNK and RARalpha reciprocally expressed with the progression of liver disease. Finally, the staining of 8-OHdG and thioredoxin was increased with the disease progression. These data indicate that JNK activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of RARalpha, suggesting that a vicious cycle between aberrant retinoid signaling and oxidative stress accelerates hepatocarcinogenesis. CI - (c) 2011 Japanese Cancer Association. FAU - Hoshikawa, Yoshiko AU - Hoshikawa Y AD - Division of Molecular and Genetic Medicine, Department of Genetic Medicine and Regenerative Therapeutics, Graduate School of Medicine, Tottori University, Yonago, Japan. FAU - Kanki, Keita AU - Kanki K FAU - Ashla, An Afida AU - Ashla AA FAU - Arakaki, Yuta AU - Arakaki Y FAU - Azumi, Junya AU - Azumi J FAU - Yasui, Toshihiro AU - Yasui T FAU - Tezuka, Yuta AU - Tezuka Y FAU - Matsumi, Yoshiaki AU - Matsumi Y FAU - Tsuchiya, Hiroyuki AU - Tsuchiya H FAU - Kurimasa, Akihiro AU - Kurimasa A FAU - Hisatome, Ichiro AU - Hisatome I FAU - Hirano, Tadamichi AU - Hirano T FAU - Fujimoto, Jiro AU - Fujimoto J FAU - Kagechika, Hiroyuki AU - Kagechika H FAU - Shomori, Kohei AU - Shomori K FAU - Ito, Hisao AU - Ito H FAU - Shiota, Goshi AU - Shiota G LA - eng PT - Journal Article DEP - 20110224 PL - England TA - Cancer Sci JT - Cancer science JID - 101168776 RN - 0 (Oxidants) RN - 0 (RARA protein, human) RN - 0 (Receptors, Retinoic Acid) RN - 0 (Retinoic Acid Receptor alpha) RN - 0 (Retinoid X Receptors) RN - 0 (Retinoids) RN - BBX060AN9V (Hydrogen Peroxide) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 3.4.25.1 (Proteasome Endopeptidase Complex) SB - IM MH - Blotting, Western MH - Enzyme Activation/*physiology MH - Hepatocytes/*metabolism MH - Humans MH - Hydrogen Peroxide/pharmacology MH - Immunohistochemistry MH - JNK Mitogen-Activated Protein Kinases/*metabolism MH - Oxidants/pharmacology MH - Oxidative Stress/*physiology MH - Proteasome Endopeptidase Complex/*metabolism MH - Receptors, Retinoic Acid/*metabolism MH - Retinoic Acid Receptor alpha MH - Retinoid X Receptors/metabolism MH - Retinoids/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - *Signal Transduction MH - Transcription, Genetic EDAT- 2011/01/29 06:00 MHDA- 2011/06/16 06:00 CRDT- 2011/01/29 06:00 PHST- 2011/01/29 06:00 [entrez] PHST- 2011/01/29 06:00 [pubmed] PHST- 2011/06/16 06:00 [medline] AID - 10.1111/j.1349-7006.2011.01889.x [doi] PST - ppublish SO - Cancer Sci. 2011 May;102(5):934-41. doi: 10.1111/j.1349-7006.2011.01889.x. Epub 2011 Feb 24.